Laurie joined MC Services in May 2016. She has twenty years of investor relations and corporate communications experience. Prior to joining MC Services, Laurie led US investors relations and corporate communications at the French biotech, Transgene. She previously served as head of IR and corporate communications for immunotherapy company, Agennix, and before that she led US IR and corporate communications for the oncology company, GPC Biotech. She began her career in IR and corporate communications at Organogenesis, a tissue engineering firm. She has spearheaded a wide range of initiatives, including raising awareness and understanding of the companies for which she worked in the investment community and press. She led IR and PR activities around a wide variety of major news events, including Phase III data readouts, M&A and leadership changes. She also advised senior management on communications strategies. She was a key team member for major financings, including a $95 million secondary offering that was coupled with a NASDAQ listing.